Stanford scientists have developed a versatile platform that uses tunable sound waves to precisely manipulate and concentrate microscopic particles, cells, and biological materials with high throughput and efficiency.
Stanford scientists have developed an optical imaging system that enables simultaneous monitoring of multiple neural signals across large brain regions with high temporal and spatial resolution.
Researchers at Stanford have developed ComBind, a computational platform that improves prediction of how drug molecules bind to their protein targets by combining structural modeling with readily available binding data from other molecules.
Old age is attributed to over fifty percent of the global disease burden. While aging is a sign of normal development early in life, it leads to the loss of youthful traits and bodily function in later years.
Saccharomyces cerevisiae strain BCY123 is provided as an ampoule containing viable cells (yeast cells, spores, or agar cubes with mycelia) suspended in cryoprotectant. This strain can be used for protein production in yeast.
Stanford researchers have developed a targeted antisense oligonucleotide (ASO) therapy to selectively reduce the expression of NaV1.7, a key sodium channel implicated in chronic pain signaling.
Stanford researchers have developed a novel class of fluorescent RNA-selective "RiboLight" dyes which enables bright, covalent, and highly specific labeling of RNA without DNA interference, delivering superior performance for imaging and quantification applications.
The limited duration of humoral responses to vaccination is a key issue in the fight against infectious diseases, as antibody levels wane over time, leaving individuals vulnerable to reinfection.
Stanford scientists have developed a cell-free method for producing high-purity plasmid DNA without the use of bacterial hosts. This approach eliminates contamination risks, reduces production time, and streamlines manufacturing for gene and cell therapies.
Researchers at Stanford have developed FiberFold, a computational tool enabling the rapid analysis of 3D chromatin architecture in conjunction with chromatin accessibility, CTCF binding, CpG methylation, and underlying genetic architecture.
Stanford researchers have developed a new class of aryl ester RNA-reactive reagents that are stable for months in water yet rapidly modify RNA upon catalytic activation, enabling reliable, scalable tools for RNA research and therapeutic applications.
Stanford researchers have developed the Broadly Usable Multi-Pass Engineered Receptor (BUMPER) architecture, a novel protein engineering platform for assembling stable, multifunctional cell surface receptors.
Diagnosis and sub-typing of inflammatory bowel disease (IBD) subsets, such as Crohn's disease (CD) and ulcerative colitis (UC), often require the use of repeated, invasive, and expensive endoscopy procedures, which are not without risk.
Stanford researchers have developed a general system to regulate the activities of specific proteins in mammalian cells using cell-permeable, synthetic molecules.